Skip to content
Calculadora Capital
LLYStocksNYSEUSD

Eli Lilly (LLY): return calculator

Eli Lilly (LLY) shares, one of the world's largest pharmaceutical companies — diabetes, obesity and oncology.

US$1,099Latest price · Jun 2026 close

Updated

Type
Stocks
Market
NYSE
Currency
USD
Sector
Healthcare
Data range
2016-06 – 2026-06 · 10 years
Source
Marketstack

US$1,000 invested 10 years ago would be worth today

US$15,351

+1,435.1% total return

Try your own values in the calculators below.

Return calculator

Pick an amount and a period to see what an investment in Eli Lilly (LLY) would be worth today. By default we include reinvested dividends (total return).

Lump sum

What a one-off investment would be worth today.

Value today
US$15,351
Total return
+1,435.1%
Annualised return
+31.4%

Monthly investing (DCA)

What investing the same amount every month would be worth.

Value today
US$80,542
Profit
US$68,442
Total invested
US$12,100

Estimate before taxes, fees and currency-conversion costs. Past performance does not guarantee future returns.

Investment growth

US$1,000US$15,351
Growth of US$1,000 invested — 2016-06 to 2026-06.

Performance

Annualised return
+31.41%
Best year (2021)
+64%
Worst year (2026)
+2%
Largest drop
-23.7%

Data for the last 10 years · 2016-062026-06

Comparison with the market

US$1,000 invested vs S&P 500 ETF (SPY):

Eli Lilly (LLY)
US$15,351
S&P 500 ETF (SPY)
US$3,975

Eli Lilly (LLY) beat S&P 500 ETF (SPY) by US$11,376 (+286%) over this period.

Risk & drawdowns

The largest peak-to-trough drop in the window was -23.7%. An investor who bought near the prior peak would have seen the investment fall significantly before recovering.

Scenarios

Illustrative results based on the available data.

  • US$1,000 5 years ago

    US$4,786

    lump sum, +378.63798361798536% return

  • US$100/mo for 5 years

    US$14,222

    invested US$6,100

  • If it repeats +31.41%/yr for 10 years

    US$15,356

    projection from US$1,000 (hypothetical)

About Eli Lilly (LLY)

Eli Lilly is one of the world's largest pharmaceutical companies, strong in diabetes, obesity (the GLP-1 family of drugs), oncology and neuroscience. Demand for these treatments has driven revenue and the share price sharply higher in recent years.

It trades on the New York Stock Exchange (NYSE) under LLY and is part of the S&P 500. As a pharma company, its value depends on clinical-trial results, regulatory approvals, patents and competition.

Related calculators

Other assets

Frequently asked questions

How much did Eli Lilly (LLY) return over the last 10 years?
+1435.1% in total, or about +31.41% per year, on a total-return basis (dividends reinvested), between 2016-06 and 2026-06.
Do these calculations include dividends?
By default yes (total return). Turn off "include dividends" to see price-only appreciation.
Do they include taxes or fees?
No. These are estimates before taxes, broker fees and currency-conversion costs.
What currency are the values in?
USD. A euro-based investor also carries EUR/USD currency risk, not reflected here.
Does past performance predict the future?
No. Past performance does not guarantee future returns; this is educational information, not advice.

Sources & methodology

Prices: Marketstack. Monthly series, total return (dividends reinvested). Data through 2026-06.

Total return assumes dividends are reinvested; you can turn that off to see price-only appreciation. Values are estimates before taxes, fees and currency-conversion costs.

Page generated and reviewed by the Calculadora Capital editorial team. Last updated 2026-06.